• FDA approves new drug to treat MS in pediatric patients

    7 monthes ago - By News Medical

    The U.S. Food and Drug Administration today approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.
    Read more ...